This HTML5 document contains 159 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n8https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34816246
rdf:type
wikibase:Item
schema:description
سائنسی مضمون научна статия מאמר מדעי artykuł naukowy 2008年论文 artigo científico 2008年论文 articol științific 2008年の論文 mokslinis straipsnis wissenschaftlicher Artikel article scientifique (publié 2008) мақолаи илмӣ 2008年論文 2008年論文 artigo científico (publicado na 2008) bài báo khoa học 2008 թուականի Յունուարին հրատարակուած գիտական յօդուած vedecký článok مقالهٔ علمی 2008年论文 2008년 논문 tudományos cikk мақолаи илмӣ tieteellinen artikkeli научни чланак 2008年论文 სამეცნიერო სტატია επιστημονικό άρθρο vědecký článek artículu científicu espublizáu en 2008 مقالة علمية vetenskaplig artikel artikulong pang-agham wetenschappelijk artikel artigo científico (publicado na 2008) scientific article vitenskapelig artikkel videnskabelig artikel (udgivet 2008) научная статья teaduslik artikkel ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2008年论文 2008年论文 naučni članak 2008 թվականի հունվարին հրատարակված գիտական հոդված article científic article scientific 2008年論文 articolo scientifico scienca artikolo บทความทางวิทยาศาสตร์ 2008年論文 2008 nî lūn-bûn 2008年論文 bilimsel makale научни чланак artículo científico publicado en 2008 artikull shkencor vitskapeleg artikkel наукова стаття, опублікована в січні 2008
p:P577
wds:Q34816246-61CAA5DB-E27A-4D3D-B6B1-4DA499A4D27E
wdt:P577
2008-01-24T00:00:00Z
p:P2888
wds:Q34816246-4011B1E3-5233-4E68-A8AE-AD623A52341C
wdt:P2888
n8:s10637-008-9115-6
p:P2860
wds:Q34816246-F7586115-61C3-44AC-B0AF-718CAE505A68 wds:Q34816246-C8E7A420-C303-4405-9B40-D4D3BD942718 wds:Q34816246-D6F54FB9-5B74-4877-ACFD-121D1B31C057 wds:Q34816246-BC9E4C8D-FB96-4043-AD6F-71F1B44047F6 wds:Q34816246-8A7E2F5C-BFB2-4095-9B5B-42EF9733BAAA wds:Q34816246-8AB39922-E4BA-41A5-94C6-AEEF71BE5816 wds:Q34816246-A6DD9010-A724-4B40-B036-C296662C925D wds:Q34816246-770CD28C-7ED4-4149-B3AB-F7FB60355F5A wds:Q34816246-794643F5-2E72-4E56-868A-2759D04C00F0 wds:Q34816246-842C9003-4028-425D-9C56-A48753370015 wds:Q34816246-6AAAFE26-7C9A-4485-B312-013C5F460067 wds:Q34816246-6C6EEF6A-BE68-45E3-85B8-849D1D7426D0 wds:Q34816246-5A0E64F2-386E-4F1C-8D0C-04CC1A882367 wds:Q34816246-4614DF27-4255-4A7F-9A74-9CF8E9D607D1 wds:Q34816246-48601EF0-C377-44FD-A436-496CEA63BF6B wds:Q34816246-51C3C66D-5EB6-4988-8D9D-22292D0CC289 wds:Q34816246-353C1963-493B-4B59-8AB8-10DF301B81A5 wds:Q34816246-035EE2AA-2D6B-42B2-8AFB-F4CAB0EACA46 wds:Q34816246-046AE123-1800-41A6-85D2-B751CAF90B39 wds:Q34816246-28E2C1D3-8704-46FD-81BC-10A4DF547381
wdt:P2860
wd:Q40227835 wd:Q28331877 wd:Q33357008 wd:Q94516013 wd:Q72114635 wd:Q54061261 wd:Q39643021 wd:Q37919763 wd:Q44899958 wd:Q79835692 wd:Q41324222 wd:Q46447353 wd:Q40302644 wd:Q44551806 wd:Q69428697 wd:Q80059427 wd:Q37790412 wd:Q44875555 wd:Q46944822 wd:Q33344022
p:P2093
wds:Q34816246-61E2298D-4567-4EB3-B5BD-13C6E177F82D wds:Q34816246-6327A6D8-559F-4EA5-BD43-6E4AB16DFCBE wds:Q34816246-E9562D68-36F5-440A-B5E4-85A927609971 wds:Q34816246-A93FEE1F-6496-4103-9558-91A4E9FB4108 wds:Q34816246-ACCD1B52-B682-4DBB-A722-98653DC98A93 wds:Q34816246-FF155817-0E9C-46E8-B6CE-1DA50FD91C8C
wdt:P2093
Olatoyosi M Odenike Shannon M Delaney Wendy Stock Devika Gajria M Eileen Dolan Theodore G Karrison
rdfs:label
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone
skos:prefLabel
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
schema:name
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
p:P50
wds:Q34816246-027158C3-9026-4258-A655-93E8782541DE wds:Q34816246-034808FB-B7AE-45F8-BF93-66CEF3851C42
wdt:P50
wd:Q87725760 wd:Q41899936
p:P1476
wds:Q34816246-882DF6F9-E8BF-484F-8B7D-49F36F69EB90
wdt:P1476
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia
p:P304
wds:Q34816246-457720AA-1D65-4DE8-8F38-3B80F74BB277
wdt:P304
233-239
p:P31
wds:Q34816246-F5C7C9A6-53A0-4F40-A195-F1D472DEF575
wdt:P31
wd:Q13442814
p:P921
wds:Q34816246-65929FB8-53A3-4566-ABD3-C728EFC75FB3 wds:Q34816246-CAAE8AAB-B525-45AA-BD7D-35FBD2409C0E
wdt:P921
wd:Q29496 wd:Q180983
p:P698
wds:Q34816246-ED605901-B247-4694-B985-99AE92D054E7
wdtn:P698
n12:18217206
wdt:P698
18217206
p:P1433
wds:Q34816246-C74E50A3-F56C-4E73-8C28-3F2F0B52A374
wdt:P1433
wd:Q2312231
p:P433
wds:Q34816246-6D1033C8-00C9-4C91-AAF2-35F134AE16D1
p:P478
wds:Q34816246-4B3BA05B-A632-492E-A642-F359EDFE42E6
wdt:P433
3
wdt:P478
26
p:P356
wds:Q34816246-33D9F59A-A2ED-45E0-8E6B-2180F95E86E4
wdtn:P356
n13:S10637-008-9115-6
wdt:P356
10.1007/S10637-008-9115-6
p:P5875
wds:Q34816246-8A314AA2-2CA2-45AF-AD07-4D457370B40D
wdt:P5875
5634933
p:P6179
wds:Q34816246-BADD08B7-A2B2-4F3F-ADD6-A3F6474822E0
wdt:P6179
1017584898
p:P932
wds:Q34816246-108E2D92-3644-496C-9365-CC43780D1329
wdt:P932
4283497